News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,838 Results
Type
Article (67301)
Company Profile (344)
Press Release (691174)
Multimedia
Podcasts (182)
Webinars (24)
Section
Business (203116)
Career Advice (3263)
Deals (38372)
Drug Delivery (149)
Drug Development (84857)
Employer Resources (191)
FDA (17494)
Job Trends (16477)
News (355335)
Policy (36556)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2996)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (50722)
ALS (182)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (347)
Approvals (17680)
Artificial intelligence (580)
Autoimmune disease (169)
Automation (38)
Bankruptcy (374)
Best Places to Work (12418)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (231)
Bladder cancer (164)
Brain cancer (64)
Breast cancer (669)
Cancer (5067)
Cardiovascular disease (450)
Career advice (2783)
Career pathing (41)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (816)
Cervical cancer (38)
Clinical research (72001)
Collaboration (1844)
Company closure (5)
Compensation (1175)
Complete response letters (73)
COVID-19 (2990)
CRISPR (98)
C-suite (887)
Cystic fibrosis (155)
Data (6345)
Decentralized trials (2)
Denatured (64)
Depression (151)
Diabetes (536)
Diagnostics (7176)
Digital health (47)
Diversity (11)
Diversity, equity & inclusion (44)
Drug discovery (273)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (243)
Earnings (84460)
Editorial (65)
Employer branding (24)
Employer resources (164)
Events (115351)
Executive appointments (1028)
FDA (20701)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1555)
Gene editing (215)
Generative AI (50)
Gene therapy (668)
GLP-1 (1135)
Government (5324)
Grass and pollen (8)
Guidances (387)
Healthcare (20630)
HIV (62)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (296)
Immuno-oncology (63)
Indications (104)
Infectious disease (3280)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (119)
Intellectual property (252)
Interviews (618)
IPO (17166)
IRA (57)
Job creations (4408)
Job search strategy (2282)
JPM (70)
Kidney cancer (16)
Labor market (89)
Layoffs (655)
Leadership (40)
Legal (8924)
Liver cancer (99)
Longevity (16)
Lung cancer (684)
Lymphoma (383)
Machine learning (44)
Management (63)
Manufacturing (849)
MASH (175)
Medical device (14711)
Medtech (14767)
Mergers & acquisitions (22306)
Metabolic disorders (1414)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (357)
Neuropsychiatric disorders (103)
Neuroscience (3133)
Neurotech (1)
NextGen: Class of 2026 (7384)
Non-profit (5078)
Now hiring (65)
Obesity (691)
Opinion (332)
Ovarian cancer (168)
Pain (218)
Pancreatic cancer (234)
Parkinson's disease (301)
Partnered (39)
Patents (512)
Patient recruitment (497)
Peanut (60)
People (60375)
Pharmaceutical (66)
Pharmacy benefit managers (33)
Phase 1 (22294)
Phase 2 (31369)
Phase 3 (23816)
Pipeline (5282)
Policy (337)
Postmarket research (3021)
Preclinical (9542)
Press Release (69)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (294)
Rare diseases (929)
Real estate (6354)
Recruiting (79)
Regulatory (27032)
Reports (54)
Research institute (2702)
Resumes & cover letters (503)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (262)
Series B (199)
Service/supplier (13)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (171)
Sponsored (46)
Startups (3932)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (101)
The Weekly (116)
Vaccines (1147)
Venture capital (98)
Weight loss (473)
Women's health (91)
Worklife (22)
Date
Today (97)
Last 7 days (612)
Last 30 days (2192)
Last 365 days (31790)
2026 (3140)
2025 (32136)
2024 (36965)
2023 (41873)
2022 (53169)
2021 (57872)
2020 (56919)
2019 (50603)
2018 (38540)
2017 (35372)
2016 (35123)
2015 (40277)
2014 (32481)
2013 (27720)
2012 (29791)
2011 (30346)
2010 (28477)
Location
Africa (1087)
Alabama (90)
Alaska (7)
Arizona (284)
Arkansas (14)
Asia (45078)
Australia (7817)
California (11507)
Canada (3296)
China (1179)
Colorado (487)
Connecticut (489)
Delaware (343)
Europe (104374)
Florida (1708)
Georgia (374)
Hawaii (4)
Idaho (65)
Illinois (921)
India (66)
Indiana (535)
Iowa (22)
Japan (436)
Kansas (126)
Kentucky (42)
Louisiana (28)
Maine (83)
Maryland (1425)
Massachusetts (8311)
Michigan (341)
Minnesota (655)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (85)
New Jersey (3050)
New Mexico (32)
New York (3051)
North Carolina (1549)
North Dakota (10)
Northern California (5568)
Ohio (349)
Oklahoma (23)
Oregon (47)
Pennsylvania (2266)
Puerto Rico (23)
Rhode Island (47)
South America (1465)
South Carolina (67)
South Dakota (1)
Southern California (4477)
Tennessee (176)
Texas (1787)
United States (41057)
Utah (350)
Vermont (1)
Virginia (278)
Washington D.C. (85)
Washington State (956)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
758,838 Results for "ac immune sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
The reprioritization effort will help AC Immune extend its cash runway through the third quarter of 2027.
September 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
November 12, 2025
·
3 min read
Press Releases
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
October 28, 2025
·
5 min read
Press Releases
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 4, 2025
·
11 min read
Press Releases
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
December 11, 2025
·
9 min read
Press Releases
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
October 27, 2025
·
6 min read
Press Releases
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
September 4, 2025
·
5 min read
Press Releases
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 6, 2025
·
10 min read
Press Releases
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
September 25, 2025
·
8 min read
1 of 75,884
Next
